Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07203248) titled 'Chinese Real-world Study of Treatment of Vestibular Migraine' on Sept. 24.

Study Type: Observational [Patient Registry]

Primary Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Condition: Vestibular Migraine Dizziness Vertigo

Intervention: Drug: CGRP R Inhibitor CGRP Inhibitor

Recruitment Status: Not recruiting

Date of First Enrollment: December 2025

Target Sample Size: 2000

To know more, visit https://clinicaltrials.gov/study/NCT07203248

Published by HT Digital Content Services with permission from Health Daily Digest....